First intention prevention: Lithium is the first intention preventive treat
ment for bipolar disorders. It the most effective choice in this indication
and provides the most benefit for the patient, particularly the young pati
ent still in the process of maturation.
Surveillance: Serum lithium must be monitored regularly. It is important fo
r the clinician to be aware of different factors which can modify serum lev
els, including disease states or iatrogenic effects related to co-prescript
ions.
Patient information: Long-term compliance and surveillance, and thus treatm
ent efficacy, depend greatly on the quality of the information provided to
the patient and his/her family.